Vitamin D and multiple sclerosis hospital admissions in Scotland

QJM: An International Journal of Medicine

Volumn 104, Issue 11, 2011, Pages 1001-1003

  Disanto, G ^a,b   Handel, A E ^a,b   Morahan, J M ^a,b   Deluca, G C ^a,b   Kimball, S M ^a,b   Hypponen, E ^c   Giovannoni, G ^d   Ebers, G C ^a,b   Ramagopalan, S V ^a,b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; COLECALCIFEROL; HLA DR ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; VITAMIN D;

ANTIGEN PRESENTATION; CORRELATION COEFFICIENT; DENDRITIC CELL; DISEASE PREDISPOSITION; DRUG MEGADOSE; EMERGENCY CARE; GENETIC ASSOCIATION; HOSPITAL ADMISSION; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL STATUS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; VITAMIN D DEFICIENCY;

EID: 84155196824     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr101     Document Type: Note

References (17)

1. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9:599-612.
2. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005; 330:120.
3. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-8.
4. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20:1352-60.
5. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008; 14:1220-4.
6. Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68:193-203.
7. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67:618-24.
8. Handel SM, Disanto G, Jarvis L, McLaughlin R, Fries A, Ebers GC, et al. Seasonality of admissions with multiple sclerosis in Scotland. Eur J Neurol 2010; doi: 10.1111/j.1468-1331.2010.03318.x [Epub ahead of Print 29 December 2010].
9. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85:860-8.
10. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010; 88:441-50.
11. Smolders J, Menheere P, Thewissen M, Peelen E, Cohen Tervaert JW, Hupperts R, et al. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 2010; 121: 243-6.
12. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009; 132(Pt 12): 3329-41.
13. Venken K, Hellings N, Liblau R, Stinissen P. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol Med 2010; 16:58-68.
14. Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, et al. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 2008; 31:271-9.
15. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007; 135:1095-6; author reply 7-8.
16. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010; 74:1852-9.
17. Kimball SM, Ursell MR, O'Connor P, Vieth R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 2007; 86:645-51.